Results for this period
Full year1 April 2025 to 31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue increased due to the effect of price revisions in the Medical Care Business and steady performance in the Nursing Care and Children's Businesses. Operating profit increased due to the effect of price revisions and growth in the Nursing Care Business, despite enhanced employee treatment and new IT investments. Net income attributable to owners of the parent decreased due to impairment losses and public tender offer-related expenses.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025 to 31 March 2026 |
| Net Sales | ¥141,144 million (YoY +2.7%) |
| Operating profit | ¥7,345 million (YoY +4.7%) |
| Ordinary income | ¥7,197 million (YoY +7.0%) |
| Profit attributable to owners of the parent | ¥3,740 million (YoY -5.6%) |
| Net income per share | ¥40.82 |
| Operating Margin | 5.2％ |
| Equity ratio | End of the current fiscal period 35.4％ / End of previous period 32.4％ |
| Total assets | ¥66,209 million |
| Net assets | ¥23,459 million |
| Cash flows from operating activities | ¥6,818 million |
| Cash flows from investing activities | ¥-548 million |
| Cash flows from financing activities | ¥-8,061 million |
| Cash and cash equivalents at end of period | ¥12,212 million |
| Full-year earnings forecast | Net Sales Not disclosed / Operating profit Not disclosed / Ordinary income Not disclosed / Net income Not disclosed / Reason No consolidated earnings forecast for FY2026 is provided because the Company is scheduled to be delisted |
| Annual Dividend Forecast | ¥11 → Not disclosed |
| Payout ratio | 26.9％ |
| Segment revenue | Healthcare Business ¥73,834 million (YoY +3.7%), Nursing Care Business ¥55,979 million (YoY +1.2%), Children's Business ¥11,286 million (YoY +4.2%) |
| Segment profit | Healthcare Business ¥4,173 million (YoY -4.9%), Nursing Care Business ¥2,750 million (YoY +24.0%), Children's Business ¥411 million (YoY +2.5%) |
| Depreciation and amortization | ¥1,459 million |
| Impairment loss | ¥751 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on redemption of investment securities ¥309 million / Extraordinary loss Impairment Losses ¥751 million, Costs related to the tender offer ¥397 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Not disclosed / Excluded Not disclosed / Company name Not disclosed / Notes No material changes to the scope of consolidation during the period |
| Material subsequent events | The public tender offer in connection with the MBO was completed, and following settlement, MP-2605株式会社 is scheduled to become the new parent company and the largest major shareholder. In addition, the Company will borrow up to ¥19 billion from MP-2605株式会社 and repay ¥14.8 billion in existing borrowings. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 94,741,793 shares |
| Treasury Shares at Period-End | 4,191,169 shares |
| Factors Behind Changes in Business Performance | Revenue increased due to the effect of price revisions in the Medical Care Business and steady performance in the Nursing Care and Children's Businesses. Operating profit increased due to the effect of price revisions and growth in the Nursing Care Business, despite enhanced employee treatment and new IT investments. Net income attributable to owners of the parent decreased due to impairment losses and public tender offer-related expenses. |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased due to the effect of price revisions in the Medical Care Business and steady performance in the Nursing Care and Children's Businesses. Operating profit increased due to the effect of price revisions and growth in the Nursing Care Business, despite enhanced employee treatment and new IT investments. Net income attributable to owners of the parent decreased due to the recognition of impairment losses in the Nursing Care and Children's Businesses and expenses related to the public tender offer in connection with the MBO.